eConsent Solutions
-
End-To-End Diagnostic Studies Powered By Technology
12/16/2022
Learn why Curebase is the only partner you need to run faster, more efficient real-world diagnostics studies from start to finish.
-
Get Your Tile Into One Home for Sites™
7/15/2024
When you "get your tile" into One Home, you're building up the library of systems available to sites for single sign-on and task management across their trials.
-
Patient Engagement By Datacubed Health
2/16/2022
Explore how the Datacubed platform supports eCOA, virtual visits, eConsent and geofencing (a frictionless way to capture adverse event data) in one solution.
-
Technology Solutions And Services Tailored For Emerging Biopharma
1/16/2024
Explore how this collection of solutions and services is transforming clinical trials and empowering emerging biopharma organizations to revolutionize medicine.
-
Advance Your Study With Medrio's Electronic Data Capture (EDC)
6/19/2023
How you capture study data can make or break your organizational success, so why settle? Medrio’s EDC technology is intuitive, scalable, and proven across over 8,000 studies.
-
eConsent: Optimize Access
4/19/2022
Learn how to optimize patient access to clinical research with a modern eConsent platform that delivers an engaging, flexible and scalable user experience.
-
How Can Phase 1 Trials Employ eClinical Solutions?
1/8/2024
Uncover how this unified platform is helping sponsors and CROs generate high-quality data, accelerate trials, and rapidly scale to Phase 2 and beyond.
-
Optimizing The Path To RSV Vaccine Approval
2/20/2024
Vaccine trials pose unique challenges; that's why sponsors and CROs trust us to navigate complexities and capture audit-ready, high-quality evidence required to get new vaccines to patients.
-
Decentralized Clinical Trials: The Future Of Clinical Research
9/26/2022
Our integrated EDC platform, including eConsent, ePRO, RTSM, and DDC, is your gateway to decentralized trials.
-
Hybrid eConsent: Remote And On-Site
3/21/2025
Studies show when participants are informed and comfortable with the consent process, they're more likely to comply with protocol, remain enrolled, and contribute to faster study deployment.